Chemistry Services for the NTP
NTP 化学服务
基本信息
- 批准号:9154486
- 负责人:
- 金额:$ 257.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-25 至 2016-05-24
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAmniotic FluidAnalytical ChemistryBlack Cohosh ExtractChemicalsChemistryContractsDevelopmentDoseDrug FormulationsEchinacea purpureaEnsureEnvironmental ExposureEpigallocatechin GallateEvaluationExposure toFetusGoalsHazard IdentificationHazardous ChemicalsHealthHeightened Cancer RiskHumanMethodsNational Toxicology ProgramOutcomePlasmaRattusRisk AssessmentRisk FactorsServicesSpecific qualifier valueTestingToxic effectToxicity TestsToxicokineticsanalogbenzotriazolebisphenol Adisorder preventionprogramspublic health researchsoundvinpocetine
项目摘要
The goal of this project is to provide support of National Toxicology Program (NTP) hazard identification activities targeted towards the prevention of diseases or adverse effects caused by environmental exposure to chemical or physical agents. Toxicity testing is an important aspect of public health research in that it serves to identify chemicals that are hazardous to human health. Proper chemical analyses are required to ensure that, in toxicity studies, the test species are exposed to the prescribed chemicals at the specified dose concentrations. This contract contributes to the ability of toxicity studies to provide evidence of heightened cancer risk along with other toxicological outcomes, by providing characterization of the chemicals studied, confirmation of the dose levels administered, and internal dose determinations. This information is critical to evaluation of toxicity tests and development of sound, scientific conclusions about the potential toxicity of the study chemical in the test species and ultimately supports the risk assessment efforts of National Toxicology Program and other federal agencies. With internal dose information provided by this contract, extrapolations to humans can be made so that the public can be adequately informed about risk factors arising from exposure to studied chemicals.
该项目的目标是为国家毒理学规划(NTP)的危害识别活动提供支持,这些活动旨在预防因环境暴露于化学或物理剂而引起的疾病或不利影响。毒性试验是公共卫生研究的一个重要方面,因为它有助于确定对人类健康有害的化学品。需要进行适当的化学分析,以确保在毒性研究中,试验物种以规定的剂量浓度暴露于规定的化学品。该合同通过提供所研究化学物质的特征、所给剂量水平的确认和内部剂量确定,有助于毒性研究提供癌症风险增加的证据以及其他毒理学结果。这些信息对于评估毒性试验和就研究化学品在试验物种中的潜在毒性得出合理、科学的结论至关重要,并最终支持国家毒理学方案和其他联邦机构的风险评估工作。根据本合同提供的内部剂量信息,可以对人类进行推断,以便公众能够充分了解暴露于所研究化学品所产生的风险因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN BURBACK其他文献
BRIAN BURBACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN BURBACK', 18)}}的其他基金
Polycyclic Aromatic Compound Mixture Assessment Program (PAC-MAP)
多环芳香族化合物混合物评估计划(PAC-MAP)
- 批准号:
9934050 - 财政年份:2014
- 资助金额:
$ 257.26万 - 项目类别:
Chemistry Services for the National Toxicology Program – Base Subproject
国家毒理学计划化学服务—基地子项目
- 批准号:
10413777 - 财政年份:2014
- 资助金额:
$ 257.26万 - 项目类别:
Chemistry Services for the National Toxicology Program (Poly- and perfluoroalkyl substances)
国家毒理学计划的化学服务(多氟烷基物质和全氟烷基物质)
- 批准号:
10708531 - 财政年份:2014
- 资助金额:
$ 257.26万 - 项目类别:
Chemistry Services for the National Toxicology Program (Mixtures Subproject)
国家毒理学计划的化学服务(混合物子项目)
- 批准号:
10708527 - 财政年份:2014
- 资助金额:
$ 257.26万 - 项目类别:
Chemistry Services for the National Toxicology Program (General)
国家毒理学计划的化学服务(一般)
- 批准号:
10810626 - 财政年份:2014
- 资助金额:
$ 257.26万 - 项目类别:
Polycyclic Aromatic Compound Mixture Assessment Program (PAC-MAP)
多环芳香族化合物混合物评估计划(PAC-MAP)
- 批准号:
10413778 - 财政年份:2014
- 资助金额:
$ 257.26万 - 项目类别:
相似海外基金
Targeting fetal lung macrophage dysregulation in congenital diaphragmatic hernia with amniotic fluid stem cell extracellular vesicle therapy
羊水干细胞胞外囊泡治疗针对先天性膈疝胎儿肺巨噬细胞失调
- 批准号:
479991 - 财政年份:2023
- 资助金额:
$ 257.26万 - 项目类别:
Operating Grants
Mechanisms of epidermal differentiation by hypoxia response and identification of amniotic fluid-derived factors
缺氧反应引起的表皮分化机制及羊水源性因子的鉴定
- 批准号:
23H02136 - 财政年份:2023
- 资助金额:
$ 257.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Early Treatment With H12-(ADP)-liposomes Ameliorates Post-partum Hemorrhage With Coagulopathy Caused by Amniotic Fluid Embolism in Rabbits.
H12-(ADP)-脂质体的早期治疗可改善兔羊水栓塞引起的产后出血和凝血病。
- 批准号:
23K08828 - 财政年份:2023
- 资助金额:
$ 257.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a novel amniotic fluid biomarker to predict the prognosis of fetal growth restriction
建立一种新型羊水生物标志物来预测胎儿生长受限的预后
- 批准号:
23K15809 - 财政年份:2023
- 资助金额:
$ 257.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of fetal stem cell therapy for cleft lip using sandwich-graft composed of bandage epithelial tissue(BET) and amniotic fluid spheroid
使用绷带上皮组织(BET)和羊水球体组成的三明治移植物开发胎儿干细胞治疗唇裂
- 批准号:
21K21032 - 财政年份:2021
- 资助金额:
$ 257.26万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Automatic Segmentation of Amniotic Fluid using Deep Learning
使用深度学习自动分割羊水
- 批准号:
565347-2021 - 财政年份:2021
- 资助金额:
$ 257.26万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Investigation of the coagulopathy involving amniotic fluid embolism: Towards development of the specific earlier assessment
涉及羊水栓塞的凝血障碍的调查:制定具体的早期评估
- 批准号:
21K16811 - 财政年份:2021
- 资助金额:
$ 257.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Verification of therapeutic effects by amniotic fluid stem cell sheet for rat myelomeningocele model.
羊水干细胞片对大鼠脊髓脊膜膨出模型治疗效果的验证。
- 批准号:
21K16599 - 财政年份:2021
- 资助金额:
$ 257.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Extracellular vesicles derived from amniotic fluid stem cells normalize glomerular function during progressive kidney disease.
来自羊水干细胞的细胞外囊泡在进行性肾脏疾病期间使肾小球功能正常化。
- 批准号:
10348192 - 财政年份:2020
- 资助金额:
$ 257.26万 - 项目类别:
Extracellular vesicles derived from amniotic fluid stem cells normalize glomerular function during progressive kidney disease.
来自羊水干细胞的细胞外囊泡在进行性肾脏疾病期间使肾小球功能正常化。
- 批准号:
10549376 - 财政年份:2020
- 资助金额:
$ 257.26万 - 项目类别: